As of January 1, 2021, life sciences companies should be prepared to comply with new reporting requirements under the Open Payments program.
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act ("SUPPORT Act"), signed in 2018, expanded the reporting obligations under the Physician Payments Sunshine Act, or Open Payments program, for data collected in calendar year 2021 and reported on or after January 1, 2022.
The SUPPORT Act extends the definition of "covered recipient" to include five new provider types: (1) physician assistants; (2) nurse practitioners; (3) clinical nurse specialists; (4) certified registered nurse anesthetists and anesthesiologist assistants; and (5) certified nurse-midwives. It also expands the nature of payment categories to include: (1) debt forgiveness; (2) long-term medical supply or device loans; and (3) acquisitions. Covered entities will also be required to report device identifiers, which is intended to standardize reported data between drugs and devices.
The expansion to non-physician practitioners will require industry stakeholders to collect data and report on substantially more covered recipients and will create data collection and reporting challenges. For example, some states do not have separate licensing for the categories of non-physician practitioner types included in the expanded definition (e.g. PA, NP, CNS, CRNA, CNM), and these practitioners may not have National Provider Identifiers.
Reporting entities should carefully monitor the implementation of updated policies and their tracking capabilities to ensure data is collected and reported accurately, and they will need to determine, on a case-by-case basis in some instances, whether certain non-physician practitioners must be included in reported data. Preliminary resources prepared by CMS to aid reporting entities can be found here.
CMS describes the Open Payments program, which requires applicable manufacturers and group purchasing organizations to report information about certain transfers of value made to covered recipients, as promoting a more transparent and accountable health-care system. The changes to the Open Payments program reflect increasing scrutiny from regulators regarding the potential for conflicts of interest arising from payments from drug and medical device companies to prescribers.
Would you like to receive our Day Pitney C.H.A.T. Newsletter? Sign up here.
Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter – April 2024
Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter – April 2024
Day Pitney Healthcare Attorneys Susan R. Huntington and Phoebe Roth authored the chapter titled "Using Enterprise Risk Management-Based Frameworks to Advance Population Health" for American Health Law Association (AHLA) and the American Society for Health Care Risk Management's (ASHRM) book titled "Enterprise Risk Management for Health Care."
Day Pitney Healthcare, Life Sciences, and Technology Counsel Damian Privitera's arrival was featured in the Law360 article "Moses & Singer Healthcare Atty Joins Day Pitney in Hartford."
Day Pitney Healthcare Partner Magda Rodriguez authored the article "When Physician Retirement Arrangements May Be Legal" for Law360.
Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter – February 2024
Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter – February 2024
Day Pitney Artificial Intelligence Committee Chair Kritika Bharadwaj and Healthcare and Technology Associate Colton Kopcik authored the article "Generative AI in Health Care: Diagnosing the Legal Landscape for Dr. GenAI" for the New York Law Journal's Legal Technology Special Section.
Day Pitney Alert
Copyright © 2024 Day Pitney LLP, all rights reserved.